- Home
- VIR vs TXO Comparison
VIR vs TXO Comparison
Compare VIR & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- TXO
- Stock Information
- Founded
- VIR 2016
- TXO 2012
- Country
- VIR United States
- TXO United States
- Employees
- VIR N/A
- TXO N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- TXO Oil & Gas Production
- Sector
- VIR Health Care
- TXO Energy
- Exchange
- VIR Nasdaq
- TXO Nasdaq
- Market Cap
- VIR 706.4M
- TXO 788.9M
- IPO Year
- VIR 2019
- TXO 2023
- Fundamental
- Price
- VIR $5.63
- TXO N/A
- Analyst Decision
- VIR Strong Buy
- TXO Strong Buy
- Analyst Count
- VIR 11
- TXO 2
- Target Price
- VIR $25.73
- TXO $21.50
- AVG Volume (30 Days)
- VIR 1.1M
- TXO 147.8K
- Earning Date
- VIR 10-30-2025
- TXO 11-04-2025
- Dividend Yield
- VIR N/A
- TXO 16.81%
- EPS Growth
- VIR N/A
- TXO N/A
- EPS
- VIR N/A
- TXO 0.30
- Revenue
- VIR $19,000,000.00
- TXO $332,267,000.00
- Revenue This Year
- VIR N/A
- TXO $32.89
- Revenue Next Year
- VIR $15.25
- TXO $10.99
- P/E Ratio
- VIR N/A
- TXO $48.23
- Revenue Growth
- VIR N/A
- TXO 15.94
- 52 Week Low
- VIR $4.16
- TXO $13.28
- 52 Week High
- VIR $14.45
- TXO $20.70
- Technical
- Relative Strength Index (RSI)
- VIR 59.22
- TXO 57.92
- Support Level
- VIR $5.36
- TXO $13.95
- Resistance Level
- VIR $6.00
- TXO $14.71
- Average True Range (ATR)
- VIR 0.28
- TXO 0.35
- MACD
- VIR 0.03
- TXO 0.07
- Stochastic Oscillator
- VIR 65.62
- TXO 70.31
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.